Form 4: Gregg Williams Increases Stake in Vivani Medical Through Open Market Purchases

Sentiment:

SEC Form 4


Director Gregg Williams reports purchasing additional shares of Vivani Medical, Inc. on the open market, increasing his indirect holdings.

Summary

  • Gregg Williams, a director and 10% owner of Vivani Medical, Inc., has reported purchasing additional shares of the company's common stock.
  • On April 9, 2025, Williams acquired 18,529 shares at a weighted average price of $1.02 per share.
  • Following this transaction, his indirectly held beneficial ownership totaled 13,822,919 shares.
  • On April 11, 2025, Williams purchased an additional 2,311 shares at $1.01 per share, bringing his total indirect ownership to 13,825,230 shares.
  • The shares are held indirectly through several entities including Gregg G. Williams 2006 Trust, Williams International Co. LLC, Sam Williams Family Investments LLC, and Sam B. Williams 1995 Generation-Skipping Trust, over which Gregg Williams has voting and dispositive power.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but the scale of the purchases is relatively small. The purchases do not appear to be part of a larger trend.

Positives

  • The director's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. However, it's important to consider the size of the purchases relative to the overall market capitalization of Vivani Medical and the individual's existing holdings.

Comparison to Industry Standards

  • Without specific industry benchmarks for insider trading activity, it's difficult to directly compare these transactions to industry standards.
  • However, monitoring insider activity is a common practice among investors to gauge sentiment and potential future performance.
  • Companies like Amgen, Eli Lilly, and Pfizer are often scrutinized for insider trading activity, and these transactions are typically compared against their historical patterns and the broader market trends.

Stakeholder Impact

  • The stock purchases could have a slightly positive impact on shareholder sentiment.

Key Dates

DateDescription
04/09/2025Gregg Williams purchased 18,529 shares of VANI at a weighted average price of $1.02.
04/11/2025Gregg Williams purchased 2,311 shares of VANI at $1.01 per share; Form 4 filing date.

Keywords

Vivani Medical, VANI, Gregg Williams, insider trading, beneficial ownership, Form 4, stock purchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.